This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Agenda – Will Special Committees Prevail in the Pandemic?
May 15, 2020
By Stephanie Forshee
Dividing duties across the full board has been the approach seen most frequently by Robin Ferracone, CEO of compensation consultancy Farient Advisors and a director on the board of pet insurance company Trupanion. She isn’t familiar with any boards that are relying on a small group of directors to take charge.
Indeed, many of the directors Agenda contacted for this article — who serve on boards of pharmaceutical, retail, financial services and insurance companies, among others — indicated that the full boards are tackling the issue, rather than a small subset of directors.
Ferracone says that there is potentially a divide in the types of companies that might have considered forming a committee. Trupanion, according to Ferracone, is among the “essential” companies that has not experienced significant declines as a result of the pandemic, since most of its customers have not opted to do away with their pet insurance. By contrast, boards serving industries like retail or travel would require all hands on deck, Ferracone says.
© 2024 Farient Advisors LLC. | Privacy Policy | Site by: Treacle Media